Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Pancreatic Cancer Screening for At-risk Individuals

for
Pancreatic Cancer, Adult
Location: Boston MA
Sponsor: Beth Israel Deaconess Medical Center

Sex: All

Age: 18 - 70+

Code: NCT05006131

Recruiting

NCI SBIR Contract for Patient Navigation Tool Prototype Development

for
Pancreas Cancer, Hepatobiliary Cancer, Patient Engagement
Location: Washington DC
Sponsor: GMG Arcdata LLC

Sex: All

Age: 18+

Code: NCT04892927

Recruiting

INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study

for
Breast Cancer, Corpus Uteri Cancer, Ovary Cancer,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT07671937

Recruiting

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

for
Pancreatic Cancer
Location: San Antonio TX
Sponsor: Lei Zheng

Sex: All

Age: 18+

Code: NCT05604560

Phase 2, Recruiting

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

for
Pancreatic Cancer, Colorectal Cancer, Hepatocellular Carcinoma
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18 - 70+

Code: NCT07627191

Early Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

for
Lung Cancer (Diagnosis), Liver Cancer, Adult, Pancreatic Cancer,
Location: Cleveland OH, St Louis MO
Sponsor: Varian, a Siemens Healthineers Company

Sex: All

Age: 21+

Code: NCT07824583

Recruiting

T Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon Cancer

for
Non-small Cell Lung Cancer, Pancreas Cancer, Colon Cancer
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06043713

Phase 1, Recruiting

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

for
Pancreatic Cancer
Location: Plantation FL, San Antonio TX, Los Angeles CA
Sponsor: Anova Innovation Limited

Sex: All

Age: 18+

Code: NCT07444541

Phase 1, Phase 2, Recruiting

EUS Procedures Using RIVOS™ EUS Access Device

for
Pancreatic Fluid Collections, Biliary Obstruction,
Location: Orlando FL
Sponsor: Orlando Health, Inc.

Sex: All

Age: 18+

Code: NCT07696572

Recruiting

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

for
Pancreatic Cancer
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06141031

Phase 1, Recruiting

Axelopran for Advanced Cancer in Patients Receiving Opioids

for
Breast Cancer, Lung Cancer, Pancreas Cancer, Prostate Cancer
Location: Saint Paul MN, Saint Louis Park MN
Sponsor: HealthPartners Institute

Sex: All

Age: 18+

Code: NCT07354919

Phase 2, Recruiting

PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC)

for
Pancreatic Cancer, Pancreatic Cancer Metastatic
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT07549958

Phase 1, Recruiting

Prehab for Pancreatic Cancer Surgery

for
Pancreatic Cancer, Adult, Prehabilitation
Location: Worester MA
Sponsor: University of Massachusetts, Worcester

Sex: All

Age: 18+

Code: NCT07478185

Recruiting

Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)

for
Pancreatic Cancer
Location: San Francisco CA
Sponsor: SONIRE Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07033689

Early Phase 1, Recruiting

PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease

for
Pancreatic Cancer
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18 - 70+

Code: NCT01102556

Recruiting

A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer

for
Pancreatic Cancer Metastatic
Location: Cleveland OH
Sponsor: Amplia Therapeutics Limited

Sex: All

Age: 18+

Code: NCT07026279

Phase 1, Phase 2, Recruiting

Sample Collection for Ongoing Research and Product Evaluation Study

for
Breast Cancer, Lung Cancer, Muscle Invasive Bladder Cancer,
Location: Austin TX
Sponsor: Natera, Inc.

Sex: All

Age: 18+

Code: NCT07318051

Recruiting

A Study of Multiparametric Ultrasound Imaging Methods

for
Pancreatic Cancer, Thyroid Nodule
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07270237

Recruiting

Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening

for
Evaluating, Intermittent Fasting, Pancreatic Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07513116

Recruiting

A First-in-Human Study of FID-022 in Solid Tumor Patients

for
Pancreatic Cancer, Cancer Cachexia
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT07249775

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial